|
|
 |
3rd Neuropsychiatric Drug Development (description) ""| Click here to register for this meeting. | | | Category: | Health & Wellness | | Address: | 120 Huntington Avenue Boston, Massachusetts, United States of America 02116 | | Phone: | 16174554188 | | Event dates: | 5/19/2020 - 5/21/2020 (This event has already taken place) | | Event web site: | http://go.evvnt.com/614469-0?pid=5188 | | findCE GPA: | This event is not yet rated. Click here to view a sample report card
Click here to rate 3rd Neuropsychiatric Drug Development |
|
Speakers/Presenters: | Topics to be Covered: | - Gopi Shanker, Novartis Institutes for Biomedical Research
- Seth Lederman, CEO and Chairman Tonix Pharmaceuticals
- Steve Paul, Karuna Therapeutics, Inc
- Kurt Rasmussen, The National Institute on Drug Abuse (NIDA)
- Patricio O'Donnell, Takeda Pharmaceuticals
- Andy Kidd, Aptinyx
- Errol De Souza, Bionomics
- Phil Skolnick, Opiant
- Jill Harkavy Friedman, American Foundation for Suicide Prevention
- Nassir Ghaemi, Novartis Institutes for Biomedical Research
- Gerard Sanacora, Yale University School of Medicine
- Sharon Mates, Intra-Cellular Therapies, Inc.
- Srikanth Gottipati, Otsuka Pharmaceuticals
- David Donabedian, Axial Biotherapeutics
- J Randall Owen, Navitor Pharmaceuticals
- Gary K. Zammit, Clinilabs Drug Development Corporation
- Rick Doblin, Multidisciplinary Association for Psychedelic Studies (MAPS)
- Christopher Missling, Anavex
- Angel Angelov, Neurocrine
- Chris Min, Cerevel Therapeutics
- Sheldon Preskorn, University of Kansas School of Medicine (UKSM)
- Al Robichaud, Sage Therapeutics
| - Science, Health and Medicine
- Pharmaceuticals
- Drug Development
|
| Contact: | info@hansonwade.com | | Organizer phone: | 16174554188 | | Offering type: | Conference | | Specialty: | Data not provided | | Event frequency: | Never | | First Meeting: | | | Total events: | | | Est. attendance: | |
| | Target audience: | Any | | Other target audiences: | | | Host Sponsor: | Hanson Wade | | Est. # of exhibitors: | | | Currency: | US Dollars | | Language: | English | | CE Credits: | | | Organizer URL | |
|
Description:With an emphasis on depressive disorders, schizophrenia, addiction and PTSD, this timely meeting provides a much-needed platform for industry and academic thought leaders to:
- Dive into novel therapeutic approaches for PTSD with Aptinyx, Bionomics, Tonix and MAPS
- Uncover the emergence of the next generation of anti-psychotics with Karuna Therapeutics and Intra-cellular Therapeutics
- Explore industry approaches for innovative trial design and new methods to modeling the placebo response with Novartis, Otsuka and Yale University
- Hear how pioneering biotechs are spearheading drug development for substance use disorders with Cerevel Therapeutics, Opiant Pharmaceuticals and NIDA
- Learn how to advance neurophysiology and cognition translational biomarkers and be part of the drive towards precision medicine with Takeda
- Uniting 80+ drug developers from all corners of the world, Neuropsychiatric Drug Development is your opportunity to discuss in depth, how to push forward the frontiers of neuropsychiatric drug development to develop the next generation of more clinically effective therapeutics. Schedule:08:00 - 16:10 Registration Fee Details:Industry Pricing: Conference + 2 Workshops: USD 4097.0,
Industry Pricing: Conference + 1 Workshop: USD 3498.0,
Industry Pricing: Conference Only: USD 2899.0,
Industry Pricing: Workshop Only: USD 699.0,
Academic: Conference + 2 Workshops: USD 3497.0,
Academic: Conference + 1 Workshop: USD 2998.0,
Academic: Conference Only: USD 2499.0,
Academic: Workshop Only: USD 599.0Other items that tuition includes:Travel and hotel arrangements:
| Contact Person: | Sophie Ellis | | Contact Email | info@hansonwade.com | | Organizer State/Province: (Outside US) | | | Organizer Country | Data not provided | | Organizer Phone | 16174554188 | | Structural makeup | Data not provided | | Host Sponsor; Other Sponsors | Hanson Wade | | Event Site/Venue | The Colonnade Hotel | | Event sold out? | No | | Multiple locations or dates? | No | | Statistics available for most recent event held in: | NA | | Average number in event attendance of: | | | Range: | | | Number in attendance of: | | | Range: | | | total attendance #: | 1000 | | Target Boundaries | International | | Is Registration contact information the same as Organizer Contact above? | NA | | Registration Contact: | | | Registration E-Mail: | | | Registration Phone: | | | Registration Fax: | | | Web Page | https://go.evvnt.com/614469-2?pid=5188 | | Can one register for your CE on your web site? | NA | | Can registration be made by snail (regular) mail? | NA | | Online housing reservations: |
| | Do you have additional written or AV materials for sale? | No | | If so, are they available for non-attendees as well as those attending? | NA | | Is full tuition necessary to ensure registration? | No | | Will there be shuttle service available? | NA | | Additional notes: | Brochure: https://go.evvnt.com/614469-3?pid=5188 |
|
 |
|